Cure Today5h
Neoadjuvant Tyvyt With Chemo Improve Responses in Resectable, Locally Advanced ESCC
In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...
Young girl diagnosed with rare and aggressive tumour after falling over while learning to walk
Nicola Francis has had 20 operations since being born after she was diagnosed with a rare and aggressive tumour after falling ...
Pharmabiz17h
EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC
EMA committee recommends extension of marketing authorisation for Janssen-Cilag’s subcutaneous Rybrevant to treat advanced EGFR-mutated NSCLC: Beerse, Belgium Tuesday, February ...
GlobalData on MSN8h
MAIA’s lung cancer therapy 99% more likely to improve OS over chemo alone
A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC ...
MAIA Biotechnology reports promising THIO trial results for NSCLC
CHICAGO - MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical-stage biopharmaceutical company with a market capitalization of $49.4 million, has announced updated data from its Phase 2 clinical ...
Cryogenic electron microscopy uncovers key cellular recycling process for human health
A team led by UT Southwestern Medical Center researchers has identified a key mechanism responsible for endosomal recycling ...
News Medical on MSN13h
Blocking a protein could halt the growth of fast-growing cancers
Preventing the cell's protein factories from making the notorious cancer-causing protein MYC could stop out-of-control tumors.